Literature DB >> 6336776

Evaluation of electrical aggregometry: comparison with optical aggregometry, secretion of ATP, and accumulation of radiolabeled platelets.

C Ingerman-Wojenski, J B Smith, M J Silver.   

Abstract

Platelet aggregation has been most commonly studied in vitro by measuring increases in light transmission as platelets aggregate in PRP. Recently, an electrical impedance method for measuring platelet aggregation has been introduced. This method can be used with either PRP or whole blood and measures an increase in impedance across electrodes placed in the blood samples as platelets accumulate on them. We have compared the results obtained by the two methods, using ADP and collagen as aggregating agents, and also have measured the secretion of platelet ATP simultaneously. Although the aggregometry results were similar, recordings obtained by the electrical method did not distinguish two waves of platelet aggregation or correlate with secretion as well as recordings obtained by the optical method. When PGI2 or PGE1 was added to the PRP, both the rate and extent of the increase in light transmittance were inhibited, but the main effect on the increase in impedance was a decrease in its rate and not in its extent. Increases in impedance and secretion of ATP were also measured in whole blood after the platelets had been labeled with a 125I-containing antibody specific for platelet surface glycoproteins. It appeared that the increases in impedance lagged several minutes behind the formation of platelet aggregates and the secretion of platelet ATP. It is suggested that there are advantages and disadvantages to both methods of measurement of platelet aggregation and that the parameters being measured must be clearly understood to properly interpret the results.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336776

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

1.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

2.  Stimulation of glycogenolysis by adenine nucleotides in the perfused rat liver.

Authors:  D B Buxton; S M Robertson; M S Olson
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

3.  Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results.

Authors:  Connie H Miller; Anne S Rice; Katherine Garrett; Sidney F Stein
Journal:  Br J Haematol       Date:  2014-03-12       Impact factor: 6.998

4.  Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.

Authors:  D A Bullough; C Zhang; A Montag; K M Mullane; M A Young
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

Review 5.  Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations.

Authors:  Nalyaka Sambu; Nick Curzen
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

6.  The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man.

Authors:  P Vallance; N Benjamin; J Collier
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.

Authors:  Hayato Iwase; Burcin Ekser; Hao Zhou; Eefje M Dons; David K C Cooper; Mohamed B Ezzelarab
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

8.  The effect of oral phenylbutazone on whole blood platelet aggregation in the dog.

Authors:  M L Jackson; G P Searcy; D W Olexson
Journal:  Can J Comp Med       Date:  1985-07

9.  Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs.

Authors:  I J Mackie; R Jones; S J Machin
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

10.  Enhancement of platelet aggregation by ursolic Acid and oleanolic Acid.

Authors:  Mikyung Kim; Chang-Ho Han; Moo-Yeol Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.